Veradigm Inc. Common Stock

Envision Pharma Group has appointed Tom Langan as its new Chief Executive Officer, bringing 30 years of experience in healthcare technology solutions. Langan previously served as interim CEO at Veradigm and has a strong background in leading technology-enabled services for life sciences companies.

Related tickers: MDRX.

The report evaluates leading companies in the life sciences real-world evidence (RWE) solutions industry, highlighting their capabilities in data integration, analytics, and patient-centric approaches. The industry is evolving with the growing demand for precision in decision-making, and the report identifies top vendors that can help pharmaceutical companies, healthcare providers, and technology organizations leverage real-world data to optimize research, clinical trials, and patient outcomes.

Related tickers: IQV, UNH, ORCL, MDRX.